Item request has been placed!

Item request cannot be made.

Processing Request

نتائج البحث

Display Settings

النتائج لكل صفحة: 10

Sort By: Relevance

Filter

فلترة النتائج

Publication : dermatologic therapy

إعادة تعيين خيارات الفبترة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children.

Authors : Abedini, Robabeh^1,2 (AUTHOR); Al-Zahawi, Saman¹ (AUTHOR); Dehghan, Soroosh¹ (AUTHOR)

Source: Dermatologic Therapy. 9/23/2024, p1-5. 5p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Tofacitinib for the Treatment of Refractory Progressive Vitiligo: A Retrospective Case Series.

Authors : Sun, Xiu-kun¹ (AUTHOR); Sheng, An-qi¹ (AUTHOR); Xu, Ai-e¹ (AUTHOR)

Source: Dermatologic Therapy. 1/11/2024, p1-5. 5p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata.

Authors : Öksüm Solak, Eda¹ (AUTHOR); Borlu, Murat¹ (AUTHOR)

Source: Dermatologic Therapy. 1/5/2024, p1-6. 6p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Bullous lichen sclerosus–generalized morphea overlap syndrome improved by tofacitinib.

Authors : Liu, Licong^1,2 (AUTHOR); Zhan, Yi^1,2 (AUTHOR); Shi, Yaqian^1,2 (AUTHOR)

Source: Dermatologic Therapy. Dec2022, Vol. 35 Issue 12, p1-5. 5p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population.

Authors : Husein‐ElAhmed, Husein^1,2 (AUTHOR) ; Abdulla, Nada^2,3 (AUTHOR); Al‐Obaidli, Amina^2,3 (AUTHOR)

Source: Dermatologic Therapy. Dec2022, Vol. 35 Issue 12, p1-6. 6p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Efficacy of oral tofacitinib in refractory chronic spontaneous urticaria and urticarial vasculitis.

Authors : Mansouri, Parvin¹ (AUTHOR); Mozafari, Nikoo^2,3 (AUTHOR) ; Chalangari, Reza⁴ (AUTHOR)

Source: Dermatologic Therapy. Dec2022, Vol. 35 Issue 12, p1-4. 4p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Tofacitinib for the treatment of erythematotelangiectatic and papulopustular rosacea: A retrospective case series.

Authors : Sun, Yan‐hong¹ (AUTHOR); Man, Xiao‐yong¹ (AUTHOR); Xuan, Xiu‐yun² (AUTHOR)

Source: Dermatologic Therapy. Nov2022, Vol. 35 Issue 11, p1-5. 5p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Effectiveness and safety of tofacitinib combined with narrowband ultraviolet B phototherapy for patients with refractory vitiligo in real‐world clinical practice.

Authors : Song, Hongbin¹ (AUTHOR); Hu, Zhonghui¹ (AUTHOR); Zhang, Shiyu¹ (AUTHOR)

Source: Dermatologic Therapy. Nov2022, Vol. 35 Issue 11, p1-9. 9p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review.

Authors : Benton, Sarah¹ (AUTHOR) ; Farah, Ronda¹ (AUTHOR); Freese, Rebecca² (AUTHOR)

Source: Dermatologic Therapy. Apr2022, Vol. 35 Issue 4, p1-6. 6p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Tofacitinib for the treatment of refractory or glucocorticoid‐dependent cutaneous leukocytoclastic vasculitis.

Authors : Ma, Jinlu¹ (AUTHOR); Lu, Wentian¹ (AUTHOR); Yan, Dong¹ (AUTHOR)

Source: Dermatologic Therapy. Nov2022, Vol. 35 Issue 11, p1-3. 3p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children.

Tofacitinib for the Treatment of Refractory Progressive Vitiligo: A Retrospective Case Series.

Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata.

Bullous lichen sclerosus–generalized morphea overlap syndrome improved by tofacitinib.

Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population.

Efficacy of oral tofacitinib in refractory chronic spontaneous urticaria and urticarial vasculitis.

Tofacitinib for the treatment of erythematotelangiectatic and papulopustular rosacea: A retrospective case series.

Effectiveness and safety of tofacitinib combined with narrowband ultraviolet B phototherapy for patients with refractory vitiligo in real‐world clinical practice.

Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review.

Tofacitinib for the treatment of refractory or glucocorticoid‐dependent cutaneous leukocytoclastic vasculitis.

اتصل بنا

اتبع